|
Author:
|
Blanco Calvo, Eduardo; Rodríguez de Fonseca, Fernando; Rivera, Patricia; Suárez, Juan; Bindila, Laura; Alén, Francisco; Rubio, Leticia; Vargas, Antonio; Pavón, Francisco Javier; Serrano, Antonia; Lutz, Beat
|
|
Notes:
|
Chronic alcohol exposure reduces endocannabinoid activity and disrupts adult neurogenesis in rodents, which results in structural and functional alterations. Cannabinoid receptor agonists promote adult neural progenitor cell (NPC) proliferation. We evaluated the protective effects of the selective CB1 receptor agonist ACEA, the selective CB2 receptor agonist JWH133 and the fatty-acid amide-hydrolase (FAAH) inhibitor URB597, which enhances endocannabinoid receptor activity, on NPC proliferation in rats with forced consumption of ethanol (10%) or sucrose liquid diets for 2 weeks. We performed immunohistochemical and stereological analyses of cells expressing the mitotic phosphorylation of histone-3 (phospho-H3+) and the replicating cell DNA marker 5-bromo-2'-deoxyuridine (BrdU+) in the main neurogenic zones of adult brain: subgranular zone of dentate gyrus (SGZ), subventricular zone of lateral ventricles (SVZ) and hypothalamus. Animals were allowed ad libitum ethanol intake (7.3 ± 1.1 g/kg/day) after a controlled isocaloric pair-feeding period of sucrose and alcoholic diets. Alcohol intake reduced the number of BrdU+ cells in SGZ, SVZ, and hypothalamus. The treatments (URB597, ACEA, JWH133) exerted a differential increase in alcohol consumption over time, but JWH133 specifically counteracted the deleterious effect of ethanol on NPC proliferation in the SVZ and SGZ, and ACEA reversed this effect in the SGZ only. JWH133 also induced an increased number of BrdU+ cells expressing neuron-specific β3-tubulin in the SVZ and SGZ. These results indicated that the specific activation of CB2 receptors rescued alcohol-induced impaired NPC proliferation, which is a potential clinical interest for the risk of neural damage in alcohol dependence.
Grant sponsor: 7th Framework Programme of European Union.
Grant number: HEALTH-F2-2008-223713, REPROBESITY to
FR and BL. Grant sponsor: Ministerio de Ciencia e Innovación.
Grant numbers: SAF2010-19087 and SAF 2010-20521 to FR.
Grant sponsor: Instituto de Salud Carlos III (ISCIII), Ministerio
de Economía y Competitividad (MINECO), UE-ERDF. Grant
number: CP12/03109 to JS. Grant sponsor: Red de Trastornos
Adictivos, ISCIII, MINECO. Grant number: RD12/0028/0001
to FR. Grant sponsor: Plan Nacional Sobre Drogas, Ministerio
de Sanidad y Consumo. Grant number: PNSD2010/143 to JS.
Grant sponsor: Consejería de Economía, Innovación y Ciencia,
Junta de Andalucía, UE/ERDF. Grant numbers: PI45403 and
CTS-8221 to FR. Grant sponsor: Consejería de Salud, Junta de
Andalucía, UE/ERDF. Grant numbers: SAS111224 to JS. Grant
sponsor: German Research Foundation DFG. Grant number:
FOR926, project CP to BL. JS, FP, and AS hold “Miguel Servet”
research contracts from the National System of Health, ISCIII
(grant numbers: CP12/03109, CP14/00212 and CP14/00173,
respectively). |
